Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Jefferson Research
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Allergan Inc gives FY 2014 guidance in line with analysts' estimates; gives Q1 2014 guidance; EPS guidance below analysts' estimates - Conference Call


Wednesday, 5 Feb 2014 11:00am EST 

Allergan Inc:Expects FY 2014 product net sales in the range of $6.650 billion to $6.950 billion.Expects FY 2014 non-GAAP diluted earnings per share in the range of $5.36 to $5.48.Expects Q1 2014 product net sales in the range of $1.525 billion to $1.600 billion.Expects Q1 2014 non-GAAP diluted earnings per share in the range of $1.09 to $1.12.FY 2014 revenue of $6.801 billion and EPS of $5.45 - Thomson Reuters I/B/E/S.Q1 2014 revenue of $1.597 billion and EPS of $1.19 - Thomson Reuters I/B/E/S. 

Company Quote

212.63
0.45 +0.21%
19 Dec 2014